Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 11Terminated 5Unknown 3Active not recruiting 3Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 993Neoplasms 852Carcinoma, Non-Small-Cell Lung 845Prostatic Neoplasms 528Neoplasm Metastasis 501Leukemia, Myeloid, Acute 489Melanoma 456Colorectal Neoplasms 447Multiple Myeloma 441Lung Neoplasms 422Pancreatic Neoplasms 353Recurrence 350Lymphoma 350Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 329Leukemia 324Leukemia, Lymphocytic, Chronic, B-Cell 302Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 245Carcinoma, Hepatocellular 234Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Myelodysplastic Syndromes 231Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

pembrolizumab 2Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Interventional × Malignant Solid Tumor × Clear all
NCT06771921 2026-01-30

A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors

Genmab

Phase 1/2 Terminated
3 enrolled
Other solid neoplasm

Malignant Solid Tumor

NCT06391775 2025-12-26

Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy

Genmab

Phase 1/2 Terminated
21 enrolled
Other solid neoplasm

Malignant Solid Tumor

NCT05859464 2025-10-20

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

Zai Lab (Hong Kong), Ltd.

Phase 1 Terminated
34 enrolled
Other solid neoplasm

Malignant Solid Tumor

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Jewish General Hospital

Phase 1/2 Terminated
5 enrolled
Other solid neoplasm

Malignant Solid Tumor

NCT01632696 2017-07-11

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Peregrine Pharmaceuticals

Phase EARLY_PHASE1 Terminated
11 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡